Biological
Octaplas
Octaplas is a biological therapy with 5 clinical trials. Historical success rate of 60.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
60.0%
Based on 3 completed trials
Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
2(40%)
Phase Distribution
Ph phase_2
1
20%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed360%
terminated240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Study of Plasma Exchange in Severe COVID-19
NCT04623255
completedphase_4
Octaplas Pediatric Plasma Replacement Trial
NCT02050841
completedphase_4
Octaplas Pediatric Plasma Exchange Trial
NCT01938378
terminated
Octaplas Adult TTP Trial
NCT01938404
terminated
Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation
NCT02037373
Clinical Trials (5)
Showing 5 of 5 trials
NCT04623255Phase 2
Study of Plasma Exchange in Severe COVID-19
NCT02050841Phase 4
Octaplas Pediatric Plasma Replacement Trial
NCT01938378Phase 4
Octaplas Pediatric Plasma Exchange Trial
NCT01938404
Octaplas Adult TTP Trial
NCT02037373
Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5